FDA approves Nucala as add-on treatment for chronic rhinosinusitis patients with nasal polyps Hina Zahid2 Aug 2021 9:00 AM ISTThe US Food and Drug Administration (FDA) has approved Nucala as a treatment for adults who have chronic rhinosinusitis with nasal polyps. Nucala...
StrataGraft for treatment of thermal burns gets FDA approval Hina Zahid16 Jun 2021 10:45 AM ISTUSA: The U.S. Food and Drug Administration has given approval to StrataGraft for the treatment of adult patients with thermal burns. Thermal burns are...
FDA Extends Approval of TRIKAFTA For Cystic Fibrosis Josepha James11 Jun 2021 9:00 AM ISTCystic fibrosis is caused by a defective protein that is the result of mutations in the CFTR gene. Although there is approximately 2,000 known cystic...
FDA Approves First Targeted Therapy for resistant Lung Cancer with specific genetic mutation Hina Zahid29 May 2021 10:00 AM ISTThe U.S. Food and Drug Administration has approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer...
US FDA approves ketamine IND for treatment of Parkinson's Disease Hina Zahid19 May 2021 10:45 AM ISTUSA: The US Food and Drug Administration (FDA) has approved PharmaTher's Investigational New Drug (IND) application to proceed with a Phase 2 clinical...
FDA approves Empaveli for treatment of paroxysmal nocturnal hemoglobinuria Medha Baranwal18 May 2021 3:15 PM ISTUSA: The US Food and Drug Administration has approved Apellis' Empaveli (pegcetacoplan) injection for the treatment of paroxysmal nocturnal...
FDA approves Zynrelef for managing postoperative pain up to 72 hours Medha Baranwal15 May 2021 7:14 AM ISTUSA: The US Food and Drug Administration (FDA) has given its approval to Heron Therapeutics' Zynrelef (bupivacaine and meloxicam) for the treatment of...
FDA expands use of Pfizer COVID-19 vaccine to Include Adolescents MD Bureau13 May 2021 8:00 AM ISTIn a recent press release, the US Food and Drug Administration (FDA) has reported that it has expanded the Emergency Use Authorization (EUA) for the...
FDA Approves Higher Dosage of Naloxone Nasal Spray to Treat Opioid Overdose Hina Zahid1 May 2021 9:00 AM ISTThe U.S. Food and Drug Administration announced today the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid...
FDA Expands Approval of valsartan for Hypertension for children below 5 years MD Bureau22 April 2021 4:18 PM ISTDiovan® (valsartan) is indicated for the treatment of hypertension to lower blood pressure in adults and pediatric patients six years of age and...
Acyclovir: How it reduces viral load and speeds up healing in herpes lesions Medical Dialogues Bureau21 April 2021 12:45 PM ISTNew Delhi: Acyclovir is a medication commonly used in the management and treatment of infections caused by the herpes simplex virus (HSV). It is...
Posimir effective for Postsurgical Analgesia approved by FDA Dr. Nandita Mohan8 Feb 2021 7:15 AM ISTPOSIMIR, a bupivacaine solution by the Durect Corporation recently got its approval from the FDA for Post-Surgical Pain Reduction for up to 72 Hours...
